医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2015年
15期
57-57
,共1页
弥散性血管内凝血%恶性肿瘤%回顾性分析
瀰散性血管內凝血%噁性腫瘤%迴顧性分析
미산성혈관내응혈%악성종류%회고성분석
Disseminated intravascular coagulation%Malignancy tumor%Retrospective analysis
目的探讨恶性肿瘤合并弥散性血管内凝血(Dis eminated Intravascular Coagulation，DIC)时，实验室检测指标DIC三项咱D-二聚体(D-dimer，DD)、纤维蛋白原降解产物(Fibrinogen Degradation Product，FDP)、抗凝血酶原II(AntithrombinII，ATII)暂和凝血常规咱凝血酶原时间(Prothrombin Time，PT)、活化部分凝血酶原时间(Activated Partial Prothrombin Time，APTT)、纤维蛋白原(Fibrinogen，FIB)检测阳性率的情况，并比较各组之间的有效性。方法回顾性分析78例恶性肿瘤患者的临床及实验室资料。结果 DD是恶性肿瘤合并DIC时诊断阳性率最高的指标。结论在肿瘤合并DIC时，DD的诊断价值最有意义。
目的探討噁性腫瘤閤併瀰散性血管內凝血(Dis eminated Intravascular Coagulation，DIC)時，實驗室檢測指標DIC三項偺D-二聚體(D-dimer，DD)、纖維蛋白原降解產物(Fibrinogen Degradation Product，FDP)、抗凝血酶原II(AntithrombinII，ATII)暫和凝血常規偺凝血酶原時間(Prothrombin Time，PT)、活化部分凝血酶原時間(Activated Partial Prothrombin Time，APTT)、纖維蛋白原(Fibrinogen，FIB)檢測暘性率的情況，併比較各組之間的有效性。方法迴顧性分析78例噁性腫瘤患者的臨床及實驗室資料。結果 DD是噁性腫瘤閤併DIC時診斷暘性率最高的指標。結論在腫瘤閤併DIC時，DD的診斷價值最有意義。
목적탐토악성종류합병미산성혈관내응혈(Dis eminated Intravascular Coagulation，DIC)시，실험실검측지표DIC삼항찰D-이취체(D-dimer，DD)、섬유단백원강해산물(Fibrinogen Degradation Product，FDP)、항응혈매원II(AntithrombinII，ATII)잠화응혈상규찰응혈매원시간(Prothrombin Time，PT)、활화부분응혈매원시간(Activated Partial Prothrombin Time，APTT)、섬유단백원(Fibrinogen，FIB)검측양성솔적정황，병비교각조지간적유효성。방법회고성분석78례악성종류환자적림상급실험실자료。결과 DD시악성종류합병DIC시진단양성솔최고적지표。결론재종류합병DIC시，DD적진단개치최유의의。
Objective To explore malignancy tumor with disseminated intravascular coagulation,which laboratory index of D-dimer、fibrinogen degradation product、AntithrombinI I、prothrombin time、activated partial prothrombin time、fibrinogen are the positive indicator.Methods Clinical and laboratory data for 78 cases of DIC with malignancy tumor were retrospectively analysed.Result:D-dimer is the most ef ective indicator of DIC with malignancy tumor.Results The diagnosis index of:DD is the highest positive rate of malignant tumor complicated with DIC. Conclusion In the tumor with DIC, the diagnostic value of DD was the most significant.
